NCT00232154 - A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions

Sinusitis

Interventions

DRUG

Zithromax (azithromycin) 500mg tablets

PROCEDURE

Endoscopic Sinus Surgery

PROCEDURE

Blood sampling for hematology

PROCEDURE

Blood sampling for plasma chemistry profile

PROCEDURE

Serum pregnancy test (for women of child-bearing potential)

Trial Locations (18)

19104

Pfizer Investigational Site, Philadelphia

27710

Pfizer Investigational Site, Durham

30912

Pfizer Investigational Site, Augusta

32216

Pfizer Investigational Site, Jacksonville

35007

Pfizer Investigational Site, Alabaster

35209

Pfizer Investigational Site, Birmingham

35216

Pfizer Investigational Site, Hoover

35233

Pfizer Investigational Site, Birmingham

35242

Pfizer Investigational Site, Birmingham

35244

Pfizer Investigational Site, Hoover

40031

Pfizer Investigational Site, La Grange

40207

Pfizer Investigational Site, Louisville

41008

Pfizer Investigational Site, Carrollton

60120

Pfizer Investigational Site, Elgin

60123

Pfizer Investigational Site, Elgin

60153

Pfizer Investigational Site, Maywood

93720

Pfizer Investigational Site, Fresno

33136-1002

Pfizer Investigational Site, Miami